Epitopes of components of the plasminogen activation system are re- exposed in formalin-fixed paraffin sections by different retrieval techniques

Journal of Histochemistry and Cytochemistry

Volumn 46, Issue 4, 1998, Pages 469-476

  Ferrier, Cilia M ^a   Van Geloof, Winny L ^a   De Witte, Hans H ^a   Kramer, Michael D ^b   Ruiter, Dirk J ^a   Van Muijen, Goos N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Antigen retrieval; Formalin fixation; Immunohistochemistry; Paraffin section; Plasminogen activation system; Protease digestion; Serine protease system

Indexed keywords

ANTIBODY; EPITOPE; FORMALDEHYDE; IMMUNOGLOBULIN; PARAFFIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ANTIGEN RETRIEVAL; ARTICLE; BREAST TUMOR; COLON TUMOR; CONTROLLED STUDY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICROWAVE RADIATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; STAINING; STROMA CELL; TISSUE SECTION; TUMOR CELL; UTERINE CERVIX TUMOR;

EID: 0031897322     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549804600406     Document Type: Article

References (31)

1. Åstedt B, Hägerstrand I, Lecander I (1986) Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost 56:63-65
2. Bianchi E, Cohen RL, Dai A, Thor AT, Shuman MA, Smith HS (1995) Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer 60:597-603
3. Bianchi E, Cohen RL, Thor AT, Todd RF, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, Smith HS (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54:861-866
4. Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M (1994) Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 54:5445-5454
5. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83-98
6. 2-macroglobulin receptor in human breast carcinomas. Int J Cancer 66:441-452
7. Constantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG (1996) Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression. An immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer 77:1079-1088
8. de Vries TJ, van Muijen GNP, Ruiter DJ (1996) The plasminogen activation system in tumour invasion and metastasis. Pathol Res Pract 192:718-733
9. Dookhan DB, Kovatich AJ, Miettinen M (1993) Nonenzymatic antigen retrieval in immunohistochemistry. Comparison between different antigen retrieval modalities and proteolytic digestion. Appl Immunohistochem 1:149-155
10. Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res 2:613-618
11. Evers P, Uylings HBM (1994) Microwave-stimulated antigen retrieval is pH and temperature dependent. J Histochem Cytochem 42:1555-1563
12. Grebenschikov N, Geurts-Moespot A, de Witte H, Heuvel J, Leake R, Sweep F, Benraad T (1997) A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols. Int J Biol Markers 12:6-14
13. Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch K-W, Loehrs U, Schildberg FW (1995) Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J Clin Oncol 13:2084-2093
14. Hsu DW, Efird JT, Hedley-Whyte ET (1995) Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147:114-123
15. Kobayashi H, Fujishiro S, Terao T (1994) Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 54:6539-6548
16. Levin EG, del Zoppo GJ (1994) Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 144:855-861
17. Mighell AJ, Robinson PA, Hume WJ (1995) Patterns of immunoreactivity to an anti-fibronectin polyclonal antibody in formalin-fixed, paraffin-embedded oral tissues are dependent on methods of antigen retrieval. J Histochem Cytochem 43:1107-1114
18. Mulcahy HE, Duffy MJ, Gibbons D, McCarthy P, Parfrey NA, O'Donoghue DP, Sheahan K (1994) Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 344:583-584
19. Nagayama M, Sato A, Hayakawa H, Urano T, Takada Y, Takada A (1994) Plaminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer 73:1398-1405
20. Pyke C, Græm N, Ralfkiør E, Rønne E, Høyer-Hansen G, Brünner N, Danø K (1993) Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911-1915
21. Quax PHA, van Muijen GNP, Weening-Verhoeff EJD, Lund LR, Danø K, Ruiter DJ, Verheijen JH (1991) Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 115:191-199
22. 2-terminal domain of the urokinase receptor. FEBS Lett 288:233-236
23. Rønne E, Høyer-Hansen G, Brünner N, Pedersen H, Rank F, Osborne CK, Clark GM, Danø K, Grøndahl-Hansen J (1995) Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. Breast Cancer Res Treat 33:199-207
24. 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds. Arch Dermatol Res 288:122-128
25. Shi S-R, Cote RJ, Taylor CR (1997) Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 45:327-343
26. Sier CFM, Fellbaum C, Verspaget HW, Schmitt M, Griffioen G, Graeff H, Höfler H, Lamers CBHW (1991) Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum. Histopathology 19:231-237
27. Stahl A, Mueller BM (1994) Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54:3066-3071
28. Takeuchi Y, Nakao A, Harada A, Nonami T, Fukatsu T, Takagi H (1993) Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study. Am J Gastroenterol 88:1928-1933
29. Taylor CR, Shi S-R, Cote RJ (1996) Antigen retrieval for immunohistochemistry. Status and need for greater standardization. Appl Immunohistochem 4:144-166
30. van Muijen GNP, Cornelissen LMHA, Jansen CFJ, Figdor CG, Johnson JP, Bröcker E-B, Ruiter DJ (1991) Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metast 9:259-272
31. Verbeek MM, de Waal RMW, Schipper JJ, Van Nostrand WE (1997) Rapid degeneration of cultured human brain pericytes by amyloid β protein. J Neurochem 68:1135-1141